Ultragenyx Pharmaceutical
RARE
$45.02
Share price
2.96%
Change (1 day)
-34.37%
Change (1 year)
Categories
EPS for Ultragenyx Pharmaceutical (RARE)
EPS in 2023 (TTM): -$14.05
According to Ultragenyx Pharmaceutical's latest financial reports the company's current EPS (TTM) is -$13.50. In 2022 the company made an earnings per share (EPS) of -$13.33 a decrease over its 2021 EPS that were of -$8.85.
EPS history for Ultragenyx Pharmaceutical from 2013 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$14.05 | 5.4% |
| 2022 | -$13.33 | 50.67% |
| 2021 | -$8.85 | 113.69% |
| 2020 | -$4.14 | -55.9% |
| 2019 | -$9.39 | 82.56% |
| 2018 | -$5.14 | -45.15% |
| 2017 | -$9.38 | 14.68% |
| 2016 | -$8.18 | 57.36% |
| 2015 | -$5.20 | 69.83% |
| 2014 | -$3.06 | 15.22% |
| 2013 | -$2.65 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 | $1.03 | -107.60% | 🇺🇸 USA |
 | -$0.84 | -93.75% | 🇺🇸 USA |
 | -$3.72 | -72.46% | 🇺🇸 USA |
 | -$0.90 | -93.36% | 🇺🇸 USA |